← Back to Search

Procedure

propylactic maze for Coronary Artery Disease (PREVENT-AF Trial)

N/A
Waitlist Available
Led By Charles L Willekes, MD
Research Sponsored by Spectrum Health Hospitals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during the procedure/surgery, up to 8 hours
Awards & highlights

PREVENT-AF Trial Summary

This trial will study whether a left-sided maze procedure can prevent postoperative atrial fibrillation (a common heart rhythm disorder).

Eligible Conditions
  • Coronary Artery Disease

PREVENT-AF Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during the procedure/surgery, up to 8 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and during the procedure/surgery, up to 8 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence of Documented Post-operative Atrial Fibrillation
Secondary outcome measures
Number of Participants Requiring Antiarrhythmic Medications in the Treatment Group Versus Control Group
Number of Participants Requiring Anticoagulants Medications in the Treatment Group Versus Control Group
Percentage of Adverse Events Related to Use of the Radiofrequency Device or Left Atrial Appendage Amputation.

PREVENT-AF Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment groupExperimental Treatment1 Intervention
Elective cardiac surgery plus prophylactic maze procedure
Group II: Control groupActive Control1 Intervention
Electric cardiac surgery only
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
propylactic maze
2020
N/A
~60

Find a Location

Who is running the clinical trial?

Spectrum Health HospitalsLead Sponsor
64 Previous Clinical Trials
553,149 Total Patients Enrolled
1 Trials studying Coronary Artery Disease
500 Patients Enrolled for Coronary Artery Disease
Charles L Willekes, MDPrincipal InvestigatorSpectrum Health Hospitals

Media Library

Prophylactic Maze (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT03604432 — N/A
Coronary Artery Disease Research Study Groups: Control group, Treatment group
Coronary Artery Disease Clinical Trial 2023: Prophylactic Maze Highlights & Side Effects. Trial Name: NCT03604432 — N/A
Prophylactic Maze (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03604432 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current status of enrollment for this clinical trial?

"According to the data available on clinicaltrials.gov, this medical trial is no longer actively accepting patients. It was first posted in February 2020 and had its most recent update in November 2022. Nevertheless, there are presently over a thousand other trials that remain open for enrollment."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Prophylactic Maze to Prevent Atrial Fibrillation in Adult Cardiac Surgery
Charles Willekes 2020. "Prophylactic Maze to Prevent Atrial Fibrillation in Adult Cardiac Surgery". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03604432.
~12 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top